VU-810930

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVU-810930
Drug Alias NameMcl-1 inhibitors (Vanderbilt University)Mcl-1 inhibitors (Vanderbilt University/ Boehringer Ingelheim)VU-013VU-810930VU-0661013
ClassificationSmall molecules
Mechanisms of ActionInduced myeloid leukemia cell differentiation protein Mcl-1 inhibitors
TargetsInduced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVanderbilt University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoehringer Ingelheim International GmbhVanderbilt University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A